Advances in hemoglobin A1c point of care technology

Journal of Diabetes Science and Technology

Volumn 1, Issue 3, 2007, Pages 405-411

  Bode, Bruce W ^a   Irvin, Benjamin R ^b   Pierce, Jeffrey A ^b   Allen, Michael ^b   Clark, Annette L ^b  

^a ATLANTA DIABETES ASSOCIATES   (United States)

^b Metrika Inc   (United States)

Author keywords

A1C; CLIA waived; Glycated hemoglobin; Hemoglobin A1c; Point of care

Indexed keywords

EID: 70749096559     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680700100314     Document Type: Review

References (17)

1. Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry, 3rd ed. Philadelphia (PA): WB Saunders; 1999.
2. CDC National Diabetes Fact Sheet, United States, 2005.
3. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917-32.
4. Phillips LS, Ziemer DC, Doyle JP, Barnes CS, Kolm P, Branch WT, Caudle JM, Cook CB, Dunbar VG, El-Kebbi IM, Gallina DL, Hayes RP, Miller CD, Rhee MK, Thompson DM, Watkins C. An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care. 2005 Oct; 28(10):2352-60.
5. Standards of Medical Care in Diabetes 2007, American Diabetes Association. Diabetes Care. 2007;30:S4-41.
6. American Association of Clinical Endocrinology Diabetes Guidelines. Endocr Pract. 2002;8:S1.
7. Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care. 1999 Nov; 22(11):1785-9.
8. www.NGSP.org
9. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE; NGSP Steering Committee. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem. 2001 Nov; 47(11):1985-92.
10. Hadjadj S, Duengler F, Barriere M, Mauco G, Coisne D, Warnier F, Sosner P, Torremocha F, Herpin D, Marechaud R. Determination of HbA1c concentrations in patients with acute myocardial infarction: comparison of the DCA 2000 device with the HPLC method. Diabetes Metab. 2005 Jun; 31(3 Pt 1):290-4.
11. Tamborlane WV, Kollman C, Steffes MW, Ruedy KJ, Dongyuan X, Beck RW, Chase P, Fox LA, Wilson DM, Tsalikian E; The Diabetes Research in Children Network (DirecNet) Study Group. Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes. 2005 Mar; 6(1):13-6.
12. St John A, Davis TM, Goodall I, Tonsend MA, Price CP. Nurse-based evaluation of point-of-care assays for glycated haemoglobin. Clin Chim Acta. 2006 Mar; 365(1-2):257-63.
13. Schwartz KL, Monsur JC, Bartoces MG, West PA, Neale AV. Correlation of same-visit HbA1c test with laboratory-based measurements: A Metro-Net study. BMC Fam Pract. 2005 Jul. 13;6:28.
14. Klonoff DC, Bergenstal RM, Cole TG, Bohannon N J V, Ammirati EB, Blatt JM, Irvin BR, Stivers CR, Clark AL. Clinical evaluation of a rapid A1C test (A1cNow) for home use. Point Care. 2006;5(3):116-20.
15. Sicard DA, Taylor, JR. Comparison of point-of-care HbA1c test versus standardized laboratory testing. Ann Pharmacother. 2005 Jun; 39(6):1024-8.
16. Fox L, Dontchev M, Ruedy K, Beck R, Kollman C, Messer L, Coffey J, Wilson D, Doyle E, Tamborlane W, Steffes M; DirecNet Study Group. Relative inaccuracy of the A1cNow in children with type 1 diabetes. Diabetes Care. 2007 Jan; 30(1):135-7.
17. Stivers CR, Baddam SR, Clark AL, Ammirati EB, Irvin BR, Blatt JM. A miniaturized self-contained single-use disposable quantitative test for hemoglobin A1c in blood at the point of care. Diabetes Technol Ther. 2000 Winter; 2(4):517-26.